Myelofibrosis: Clinicopathologic Features, Prognosis, and Management Page 1 Clinical
Advances in Hematology & Oncology Volume 16, Issue 2 February 2018 121 Myelofibrosis …

Understanding the genetic and nongenetic determinants of tumor protein 53 (TP53)-
mutation-driven clonal evolution and subsequent transformation is a crucial step toward the …

Myeloproliferative neoplasms (MPN) are a group of disorders defined by clonal proliferation
of mature myeloid cells with overlapping clinical features. The driver mutations of these …

Myeloproliferative neoplasms (MPNs) are haematopoietic stem cell-derived clonal disorders
characterised by proliferation of some or all myeloid lineages, depending on the subtype …

Myelofibrosis is a severe myeloproliferative neoplasm characterized by increased numbers
of abnormal bone marrow megakaryocytes that induce fibrosis, destroying the hematopoietic …

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to
Hydroxycarbamide in a Randomized Trial - PMC Back to Top Skip to main content NIH NLM …

We have identified a migraine locus on chromosome 19p13. 3/2 using linkage and
association analysis. We isolated 48 single-nucleotide polymorphisms within the locus, of …

PAC203 is a randomized dose-finding study of pacritinib, an oral JAK2/IRAK1 inhibitor, in
patients with advanced myelofibrosis who are intolerant of or resistant to ruxolitinib. Patients …

Patients receiving targeted cancer treatments such as tyrosine kinase inhibitors (TKIs) have
been classified in the clinically extremely vulnerable group to develop severe acute …

Objectives This study assessed students' awareness of radiation exposures and determined
the impact a curriculum in clinical radiology (CICR) had on awareness. Methods Six …